FDA applicant
Pharmacia Diagnostics, Inc.
FDA records 10 decisions for Pharmacia Diagnostics, Inc. (Columbia, MD) from 1990 to 2006: 10 510(k) clearances. Most are in product codes LGD (Enzyme Linked Immunoabsorbent Assay…) and LFX (Enzyme Linked Immunoabsorbent Assay, Rubella). Its devices cite 2 predicates, 0 of them its own earlier devices. 3 recalls are linked to its devices.
FDA’s records also spell it “Pharmacia Diagnostics AB”, “Pharmacia Diagnostics GmbH & Co. KG”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Pharmacia Diagnostics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Pharmacia Diagnostics, Inc. since 2007.
Recalls per year
1in 2019
Class I Class II/III not classified
Planning a device like Pharmacia Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Pharmacia”
FDA records each applicant name separately; these may or may not be the same firm.